Pediatric Neurology News

Researchers observed no difference in functional neurodevelopment or epilepsy among children aged 24 months regardless of whether antiseizure medication was discontinued or maintained in infants at discharge once seizures ceased.

The beta-blocker propranolol showed potential in treating certain autism symptoms, according to an initial analysis of a small, double-blinded, placebo-controlled trial.

Early intervention for children with or at high risk for cerebral palsy should begin “as soon as possible” in order to build on “a critical developmental time,” according to results of a systematic review published in JAMA Pediatrics.

The American Academy of Neurology released an update to their 2014 position statement on telehealth in which they reiterate their call for expanding its use.

Overweight and obesity appeared significantly associated with neurocognitive impairment during long-term follow-up of individuals who received chemotherapy for childhood acute lymphoblastic leukemia, according to a study published in Cancer.

Risk for permanent disability in pediatric-onset MS decreased by 50% to 70% in an analysis of four diagnostic time points starting in 1993, likely due to improvements in treatment standards, according to results published in JAMA Neurology.

A study demonstrating that galantamine, a cholinesterase inhibitor, significantly reduced risk for severe dementia over a 5-year period among patients with Alzheimer’s led neurology coverage in April.

This April marks the first Autism Acceptance Month, according to the Autism Society.

Young patients with spina bifida present with ophthalmic complications at a high rate, according to a poster presented at the virtual American Association for Pediatric Ophthalmology and Strabismus annual meeting.

Avalglucosidase alfa provided “substantial improvements in clinically meaningful outcome measures” and a more favorable safety profile for late-onset Pompe disease compared with Lumizyme, according to findings from the phase 3 COMET trial.